about
Pathogenesis of group A streptococcal infectionsComparative analysis of emm type pattern of Group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factorRelationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenesLocal Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen.Spa contributes to the virulence of type 18 group A streptococci.Immunogenicity of a 26-valent group A streptococcal vaccine.Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenesMolecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, UtahDisease manifestations and pathogenic mechanisms of Group A Streptococcus.Group A streptococcus expresses a trio of surface proteins containing protective epitopes.Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response.New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciActive and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococciProspects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: population genetics, human serologic response, and gene transcription.Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children.Invasive group a streptococcal infections, IsraelVaccination against rheumatic heart disease: a review of current research strategies and challenges.Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.Towards developing a vaccine for rheumatic heart disease.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity.
P2860
Q29615547-3323815F-6A99-47AC-9C57-1C6DF0C364A1Q33369963-A0173768-9C80-4B14-B232-2B67384B3D0AQ33398535-8858BDAE-B01A-426E-BD00-0AEEF9B1805BQ33570612-BC8C996E-7A46-47F0-9753-44A8767AF0E9Q34005105-E904FBC5-7D97-4E4B-8F4B-04EC313780C4Q34007193-71CAED10-F6D2-4135-AEE3-41C2DA642B7FQ34121015-AFD24CBD-6A78-4FE7-BFBA-4374DB222D99Q34127696-E4D41BDA-08C1-4B62-B410-70018701F3B9Q34202889-6AEE552E-F4BA-41B6-B4C0-30E815C1FA67Q34413457-A40DCF9D-EC78-46D5-B356-C6EEBCBBF847Q34701389-DA0B1449-ADD1-49CD-9969-A0F17B9D8DBFQ34839724-75AA289A-64A3-4834-9696-18AF6C1179D0Q35376757-55A7EBEA-E714-483C-A0D4-C291EA8F842EQ35913574-58E56E32-2D0F-4C5B-B133-126C7F6435A6Q36257688-BD645889-A481-4A43-8547-9569127DBB63Q36315066-2D985AEF-347B-45FE-BAA5-63A196C7DB12Q36616151-03BECAD3-B687-4549-AC11-8E9E4A3525F9Q37314025-A123DAAA-2D86-45B0-9D15-49071E124741Q38021366-554865DC-F3DE-42F2-B215-14A5E5A1B5F7Q39863755-9AB07CC4-9561-47FF-BF4E-6D5DC4075EF0Q40498619-6D78AB9B-122F-4217-A73A-ABA0A62B6C64Q41928281-67C8021C-7C3A-4ABD-921C-8E26F52EE941Q47576940-F584823C-CC44-474E-B401-80FAA5D40D92Q51192278-8DA072A2-DC44-42A1-9E0A-B7AEE1C286CF
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
New protective antigen of group A streptococci.
@ast
New protective antigen of group A streptococci.
@en
type
label
New protective antigen of group A streptococci.
@ast
New protective antigen of group A streptococci.
@en
prefLabel
New protective antigen of group A streptococci.
@ast
New protective antigen of group A streptococci.
@en
P2093
P2860
P356
P1476
New protective antigen of group A streptococci.
@en
P2093
P2860
P304
P356
10.1172/JCI5118
P407
P577
1999-05-01T00:00:00Z